Orion Corporation

Orion Corporation is a global Finnish pharmaceutical manufacturer and active pharmaceutical ingredient supplier headquartered in Espoo, Finland. The company develops, manufactures, and markets human prescription drugs, generic medicines, over-the-counter self-care products, and veterinary pharmaceuticals. Key core focus therapy areas include oncology, respiratory diseases, neurological disorders, pain management, and women's health. The organization operates six manufacturing plants across Finland, along with production facilities in France and Belgium, including active pharmaceutical ingredient synthesis at its Hanko and Oulu locations. In addition to finished dosage forms, the enterprise supplies custom active pharmaceutical ingredients and active ingredient intermediates to pharmaceutical companies globally. Research and development operations are conducted through dedicated R&D centers located in Finland, the United Kingdom, and the United States. Its consumer healthcare product portfolio comprises non-prescription medications, dietary supplement vitamins, and specialized skincare formulations distributed across European and Asia-Pacific markets. Commercial distribution and sales operations span more than one hundred countries, serving healthcare providers, pharmacies, and livestock managers worldwide.